Amedeo's Top 20

Amedeo Smart

Independent Medical Education


01 July 2013

Multidisciplinary Journal Club

  1. Heneghan MA , Yeoman AD, Verma S, Smith AD, et al.
    Autoimmune hepatitis.
    Lancet 2013.

  1. Boyd MA , Kumarasamy N, Moore CL, Nwizu C, et al.
    Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regim
    Lancet 2013;381:2091-9.

  2. Foa R , Guarini A.
    A Mechanism-Driven Treatment for Chronic Lymphocytic Leukemia?
    N Engl J Med 2013.

  3. Hellstrom A , Smith LE, Dammann O.
    Retinopathy of prematurity.
    Lancet 2013.

  4. Wang ML , Rule S, Martin P, Goy A, et al.
    Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma.
    N Engl J Med 2013.

  1. Dans AL , Connolly SJ, Wallentin L, Yang S, et al.
    Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Circulation 2013;127:634-40.

  2. Saver JL , Fonarow GC, Smith EE, Reeves MJ, et al.
    Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.
    JAMA 2013;309:2480-8.

  3. Bonderman D , Ghio S, Felix SB, Ghofrani HA, et al.
    Riociguat for Patients with Pulmonary Hypertension due to Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study.
    Circulation 2013.

  4. Mahfoud F , Ukena C, Schmieder RE, Cremers B, et al.
    Ambulatory Blood Pressure Changes after Renal Sympathetic Denervation in Patients with Resistant Hypertension.
    Circulation 2013.

  5. Byrd JC , Furman RR, Coutre SE, Flinn IW, et al.
    Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia.
    N Engl J Med 2013.

  1. Brookhart MA , Freburger JK, Ellis AR, Wang L, et al.
    Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients.
    J Am Soc Nephrol 2013.

  2. Cnattingius S , Villamor E, Johansson S, Edstedt Bonamy AK, et al.
    Maternal obesity and risk of preterm delivery.
    JAMA 2013;309:2362-70.

  3. Lazaridis C , Neyens R, Bodle J, DeSantis SM, et al.
    High-osmolarity saline in neurocritical care: systematic review and meta-analysis.
    Crit Care Med 2013;41:1353-60.

  4. Zukin M , Barrios CH, Rodrigues Pereira J, De Albuquerque Ribeiro R, et al.
    Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non-Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2.
    J Clin Oncol 2013.

  5. Sandborn WJ , Feagan BG, Marano C, Zhang H, et al.
    Subcutaneous Golimumab Maintains Clinical Response in Patients with Moderate-To-Severe Ulcerative Colitis.
    Gastroenterology 2013.

  1. Tan D , Horning SJ, Hoppe RT, Levy R, et al.
    Improvements in observed and relative survival in follicular grade 1-2 lymphoma over four decades: the Stanford University experience.
    Blood 2013.

  2. Skjerven HO , Hunderi JO, Brugmann-Pieper SK, Brun AC, et al.
    Racemic adrenaline and inhalation strategies in acute bronchiolitis.
    N Engl J Med 2013;368:2286-93.

  3. Thomsen M , Ingebrigtsen TS, Marott JL, Dahl M, et al.
    Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    JAMA 2013;309:2353-61.

  4. Johansson H , Kanis JA, Oden A, McCloskey E, et al.
    A meta-analysis of the association of fracture risk and body mass index in women.
    J Bone Miner Res 2013.

  5. Kiesewetter B , Raderer M.
    Antibiotic therapy in non-gastrointestinal MALT lymphoma: a review of the literature.
    Blood 2013.


more..


Privacy Policy